XML 99 R76.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Aug. 30, 2021
Aug. 26, 2021
Apr. 30, 2021
Apr. 07, 2021
Feb. 28, 2021
Feb. 22, 2021
May 13, 2020
Apr. 22, 2020
Mar. 13, 2020
Mar. 25, 2021
Oct. 30, 2020
Mar. 26, 2020
Feb. 14, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Sep. 15, 2020
Equity (Details) [Line Items]                                  
Preferred stock, shares authorized                           2,000,000 2,000,000    
Preferred stock, par value (in Dollars per share)                           $ 0.0001 $ 0.0001    
Ordinary shares authorized                           200,000,000 200,000,000    
Ordinary par value (in Dollars per share)                           $ 0.0001 $ 0.0001    
Shares issued                       800,000          
Additional ordinary shares new issues               5,000,000                  
Common stock, shares issued                           68,124,402 68,122,402    
Weighted-average exercise price per share (in Dollars per share)         $ 5                        
Underwriting agreement, description           the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Univest Securities, LLC (“Univest”), as the representative of the several underwriters named therein (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell (i) 3,810,976 ordinary shares of the Company (“Offered Shares”), par value of $0.0001 per share (the “Ordinary Shares”) and (ii) warrants (the “Warrants”) to purchase an aggregate of 3,810,976 Ordinary Shares (the “Warrant Shares”) in an underwritten public offering (the “Offering”). In addition, the Company has granted the Underwriters a 45-day option (the “Over-Allotment Option”) to purchase up to an additional 571,646 Ordinary Shares (the “Option Shares”) and Warrants to purchase up to 571,646 Ordinary Shares at the public offering price, less underwriting discounts and commissions. The Offered Shares and Warrants are delivered on February 24, 2021, at a public offering price of $3.28 per share and associated warrant to purchase one ordinary share, as set forth in the Underwriting Agreement, subject to the satisfaction of certain closing conditions.                      
Additional ordinary shares 571,428                                
Warrants to purchase 571,428                                
Issuance of additional shares     5,000,000                            
Sale of ordinary shares   2,857,142                              
Total gross proceeds (in Dollars)   $ 10,000,000                              
Exercise price per share (in Dollars per share)   $ 4.4                              
Fixed combined purchase price (in Dollars per share)   $ 3.5                              
Ordinary shares vested       2,000                          
Common stock, shares outstanding                           68,124,402 68,122,402    
Public Warrants Years                           5 years      
Public warrants, description                           The Company may redeem the Public Warrants:  ●in whole and not in part;   ●at a price of $0.01 per warrant;   ●at any time while the Public Warrants are exercisable;   ●upon no less than 30 days’ prior written notice of redemption to each Public Warrant holder;   ●if, and only if, the reported last sale price of the Company’s ordinary shares equals or exceeds $18.00 per share, for any 20 trading days within a 30 trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and   ●if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.        
Public warrants outstanding                           25,000,000 25,000,000    
Issued shares in connection exchange of public rights                           2,504,330      
Net profit , percentage                           10.00%      
Statutory reserve capital percentage                           50.00%      
Non controlling interest rate                           49.00%   49.00%  
Common Stock [Member]                                  
Equity (Details) [Line Items]                                  
Common stock, shares issued                             68,122,402    
Common stock, shares outstanding                           68,124,402      
Consulting and Media Amplification Agreement [Member]                                  
Equity (Details) [Line Items]                                  
Agreement, description             pursuant to which the Company agreed to pay up to$300 in cash and issue 112,500 ordinary shares of the Company for the performance of certain services by Consortium for the Company. Consortium has received $180 in cash and the full 112,500 Shares for services rendered pursuant to the Consulting Agreement. The Company issued to Consortium another 20,000 ordinary shares on October 16, 2020 for settlement payment.                    
Over-Allotment Option [Member]                                  
Equity (Details) [Line Items]                                  
Additional ordinary shares                   571,646              
Warrants to purchase                   571,646              
Price per ordinary share and associated warrant (in Dollars per share)                   $ 3.28              
IPO [Member]                                  
Equity (Details) [Line Items]                                  
Warrant, description                           Pursuant to the Initial Public Offering, TKK sold 25,000,000 Units at a purchase price of $10.00 per Unit, inclusive of 3,000,000 Units sold to the underwriters on August 22, 2018 upon the underwriters’ election to partially exercise their over-allotment option. Each Unit consists of one ordinary share, one warrant (“Public Warrant”) and one right (“Public Right”). Each Public Warrant entitles the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per whole share. Each Public Right entitles the holder to receive one-tenth of one ordinary share at the closing of a Business Combination.       
Advertising [Member]                                  
Equity (Details) [Line Items]                                  
Shares issued                 125,000                
Price per share (in Dollars per share)                 $ 2.45                
Yijincheng [Member]                                  
Equity (Details) [Line Items]                                  
Additional ordinary shares new issues                 200,000                
Stock per shares (in Dollars per share)                 $ 2.45                
Xingxian Li [Member]                                  
Equity (Details) [Line Items]                                  
Common stock, shares issued                                 100,000
Hong Kong Duoku Limited [Member]                                  
Equity (Details) [Line Items]                                  
Agreement, description                     the Company entered into a subscription agreement with Hong Kong Duoku Limited (“Duoku”), pursuant to which the Company will issue 193,986 of ordinary shares at $10.31 per share to Duoku. On November 17, 2020, the Company has completed such issuance of 193,986 ordinary shares at a purchase price of $10.31 per share.            
Designated Holder of Fortune Path Limited [Member]                                  
Equity (Details) [Line Items]                                  
Common stock, shares issued                                 100,000
Closing price (in Dollars per share)                                 $ 3.12
Early Bird Capital [Member]                                  
Equity (Details) [Line Items]                                  
Cash fees (in Dollars)                           $ 8,750      
Transaction value, percentage                           1.00%      
Description of fee amendment                         Under the Fee Amendment, EarlyBirdCapital agreed to reduce its fee of $8,750 due under the Original Agreement and forgo reimbursement of expenses in exchange for a convertible promissory note in the amount of $4,000 without interest (“EBC Note”). The EBC Note is for a period of one year and is convertible, at EarlyBirdCapital’s option, into the Company’s ordinary shares at the conversion price equal to the volume-weighted average price of the Company’s ordinary shares on Nasdaq or such other securities exchange or securities market on which the Company’s ordinary shares are then listed or quoted, for the ten trading days prior to such conversion date; provided, however, the conversion price shall not be less than $5.00 (the “Floor Price”)        
TKK [Member]                                  
Equity (Details) [Line Items]                                  
Ordinary shares issuable upon the conversion         280,000                        
Horgos Glary Wisdom [Member]                                  
Equity (Details) [Line Items]                                  
Non controlling interest rate                             49.00% 49.00%